Healthcare Industry News: augmented reality
News Release - April 15, 2019
Thermo Fisher Scientific Introduces World's First Smart qPCR InstrumentsQuantStudio 6 and 7 Pro Real-Time PCR Systems leverage advanced capabilities to maximize efficiency and increase productivity in the laboratory
CARLSBAD, Calif., April 15, 2019 -- (Healthcare Sales & Marketing Network) -- Thermo Fisher Scientific today launched the Applied Biosystems QuantStudio 6 and 7 Pro Real-Time PCR Systems, the world's first Smart qPCR instruments. Capabilities include facial authentication, voice commands, radio-frequency identification (RFID)-enabled plate scanning, and quick access to service and support with a single touch. The QuantStudio 6 Pro Real-Time PCR System leverages advanced capabilities, such as facial authentication and voice-activated commands, to maximize efficiency and increase productivity in the laboratory.
qPCR remains the most broadly adopted and leveraged genetic analysis technology in the life sciences industry, but what has been missing are modern features to improve the user-instrument interaction. Now, with smart features that include quick and secure log-in through facial authentication, and hands-free operation with voice-activated commands, productivity and the overall user experience is transformed.
QuantStudio Pro instruments use RFID-enabled Applied Biosystems TaqMan Array Plates for seamless upload of plate layout and assay information for setting up the run. This eliminates manual data entry, reduces potential errors and improves experimental reproducibility. Results from experiments can then be analyzed remotely from any desktop computer or smart phone using the Instrument Connect mobile app.
Support on the new system is also now expedited with the new Smart Help feature, which provides instant access to service and support professionals. Through this feature, all relevant diagnostic information is forwarded to an on-call team member and, when possible, corrective action may be completed remotely using augmented reality technology. All these innovations are delivered on an instrument with a smaller footprint that consumes 26 percent less energy than its predecessor.
"QuantStudio Pro qPCR systems deliver everything you would expect from the Applied Biosystems brand and more," said Will Geist, vice president and general manager of qPCR for Thermo Fisher Scientific. "What makes Pro transformational is the integration of smart features that support a fundamentally better and more productive user experience."
Learn more at www.thermofisher.com/quantstudiopro
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.
Source: Thermo Fisher Scientific
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.